Clinical trial Recruiting at 1 site Interventional Ages 12 to 21

Triple-daily 15 mA tACS for adolescent nonsuicidal self-injury

Official title: Efficacy of Triple-daily 15mA Transcranial Alternating Current Stimulation on Adolescent Non-suicidal Self-injury (NSSI): a Double-blind, Randomized, Sham-controlled Trial

Run by Shanghai Mental Health Center · NCT06919432 · Data updated 2026-11-12

The researchers will test whether triple-daily 15 mA transcranial alternating current stimulation (tACS) can reduce nonsuicidal self-injury in adolescents aged 12–21 by comparing active versus sham stimulation.

More Non-suicidal Self-injury trials

Quick facts

Study typeInterventional
Ages12 Years to 21 Years
SexAll
Enrollment66 (estimated)
SponsorShanghai Mental Health Center
Academic / other
Locations1 site (Shanghai, Shanghai Municipality)
StatusRecruiting
StartedMay 1, 2025
Main results expectedSeptember 30, 2027
Study endsSeptember 30, 2027
Registry record updatedNovember 2, 2026
Trial IDNCT06919432 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are 12–21-year-olds who meet DSM-5 criteria for NSSI with five or more episodes in the past year (and at least one in the past month), who are not taking psychotropic medication and have no prior neurostimulation exposure, and who can provide consent with guardian permission as required.

Probably not a fit

Patients with elevated or imminent suicidal risk, neurological implants or disorders, pregnancy or lactation, prior neurostimulation exposure, current psychotropic medication use, or inability to attend the intensive in-person sessions are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adolescents with recurrent nonsuicidal self-injury are randomized to receive either active or sham tACS targeting the forehead and both mastoids. The intervention features an intensive phase of triple-daily 15 mA sessions totaling 40 sessions over two weeks, followed by weekly follow-up observations for four weeks. EEG and ECG are recorded at baseline, after the first session, at the end of the intensive phase, and at a six-week follow-up to track physiological and clinical changes. All evaluations are performed under standardized conditions to compare clinical recovery between active and sham groups.

Why it matters

Potential benefit: If successful, this could provide a noninvasive treatment option that reduces the frequency or severity of nonsuicidal self-injury in adolescents.

How similar studies have gone: Use of tACS specifically for adolescent NSSI is novel and largely untested, though related noninvasive brain stimulation approaches (TMS/tDCS) have shown mixed and preliminary results for self-harm–related outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of Non-Suicidal Self-Injury (NSSI) according to the DSM-5 Section III diagnostic criteria, including:

Criterion A: At least five or more NSSI episodes in the past year.

Criterion B: NSSI is expected to relieve interpersonal difficulties, negative thoughts or emotions, or induce a positive emotional state.

Criterion C: Prior to NSSI, the individual experiences one or more of the following: interpersonal problems, negative thoughts or emotions, distress that is difficult to control, or frequent preoccupation with NSSI.

Criterion D: NSSI is socially unacceptable or limited to minor self-injury.

Criterion E: NSSI causes clinically significant distress or impairment in social, academic, or other important areas of functioning.

Criterion F: NSSI is not better explained by psychotic disorder, delirium, substance use/withdrawal, or another medical or mental disorder.

* At least one NSSI episode in the past month.
* Age 12 to 21 years.
* Informed consent obtained from participants; for those under 18, consent must also be obtained from parents or legal guardians.

Exclusion Criteria:

* Current or past organic brain disorders or neurological disorders.
* High or imminent risk of suicide, as assessed by clinicians during routine screening.
* Previous or current exposure to electroconvulsive therapy (ECT), modified ECT, transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS), tACS, or other neurostimulation treatments.
* Presence of cochlear implants, cardiac pacemakers, implanted medical devices, or metal in the brain.
* Previous or current use of psychoactive or psychotropic substances.
* Pregnancy or lactation.
* Participation in another ongoing clinical trial.
* Refusal to provide informed consent to participate.
* Other circumstances deemed unsuitable for participation by the investigators.

Where it's running

  • Shanghai Mental Health Center
    Shanghai, Shanghai Municipality, China
    Recruiting

Study contacts

  • Principal investigator: TianHong Zhang, Doctor — Shanghai Mental Health Center
  • Study coordinator: TianHong Zhang, Doctor
  • Email: zhang_tianhong@126.com
  • Phone: 13127577024

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.